All Mercy services are open. See safe options for care and the latest COVID-19 vaccine information.
Uterine cancer forms in various areas of the uterus, but it’s most commonly found in the inner lining of the uterus as endometrial cancer. Uterine cancer is the most common gynecologic cancer, and it’s found most frequently among women who have gone through menopause.
Mercy is a leader in diagnosing and treating gynecologic cancers, including all stages and types of uterine cancer. We’ll provide you with the best care possible, and our team of cancer experts can help design a treatment plan based on your needs.
There are two main types of uterine cancer and each type forms in a different part of the uterus.
Cancer that begins in the lower part of the uterus (known as the cervix) is known as cervical cancer.
While there are several risk factors for endometrial cancer, a hormonal imbalance is considered one of the main risk factors. An excess of the hormone estrogen can increase the risk of endometrial cancer. Some risk factors like age and family history are out of your control, but there are many risk factors that you can control through your lifestyle.
Some endometrial cancer risk factors include:
There are no uterine cancer screening exams for women with average risk and no symptoms. If you have some of the factors that put you at a higher risk, talk with your doctor about other procedures to help identify endometrial cancer early. You can help lower the risk of endometrial cancer by:
Early signs of endometrial cancer are abnormal bleeding and discharge. Additional signs and symptoms of uterine cancer may include:
If you’re experiencing symptoms of uterine cancer, it can be overwhelming. Mercy's expert care teams have the knowledge and advanced technology to diagnose and treat your cancer.
Learn about uterine cancer diagnosis & treatment options here.
At Mercy, we offer comprehensive testing services to diagnose endometrial cancer, including:
At Mercy, we offer compassionate care for a variety of treatment options for endometrial cancer, including: